Analytical Data
-
Gene name
PRR18
- Application
-
Alternative Names
PRR18; Proline-rich protein 18
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N4B5
-
Expression Region
1-295 aa
-
AA Sequence
MPFPPMPPPP APAPGAQAAR QLPRRPCAAG DKKKRPPQRP EGLLSSSWPS ATLKRPPARR GPGLDRTQPP APPGVSPQAL PSRARAPATC APPRPAGSGH SPARTTYAAT SAGTGTTAAG TSSGAGPCPD SAARFCLNLT PEAVLVIQKR HLEKQLLARP RRPFPSPSAE PRRLLAPCLP ARAAGPRRGG PASDPDAPPT AGQGRRAPPP GAQLLHGGLQ VPQLSPRPGA LRPMLKVSLL NERHRYDDVE YEEEPEAVDE GLVRKCTEWL RGVESAAAAR GRAGALDSRR HLSTL
-
Molecular Weight
30.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PRR18 (Proline-Rich Protein 18) is a member of the proline-rich protein family, which is known for its involvement in various cellular processes, including cell signaling, adhesion, and response to environmental stress. Research into PRR18 has gained momentum due to its association with critical biological functions and potential implications in human diseases, particularly in the context of cancer and inflammatory conditions. Studies have indicated that PRR18 may play a role in modulating the immune response, influencing cell proliferation, and affecting the tumor microenvironment. Its expression levels and functional properties have been linked to various oncogenic pathways, making it a candidate for further investigation as a potential biomarker or therapeutic target. Recent advances in molecular biology techniques have facilitated the cloning and expression of PRR18 as a recombinant protein, paving the way for in-depth studies of its structure and function. Understanding the specific mechanisms through which PRR18 operates can provide valuable insights into its biological significance and therapeutic potential. Additionally, the development of PRR18-based assays could enhance our ability to study its role in pathophysiological conditions, ultimately contributing to the advancement of targeted therapies in oncology and immunology. Given these aspects, ongoing research into PRR18 presents a promising avenue for uncovering novel strategies for disease intervention and management.
